Updated: Jul 3
CEO Stefan Tell has decided to look for new opportunities outside CarpoNovum.
We would like to thank Stefan for his contribution.
As a consequence, Anders Grönberg has been reinstated as CEO of CarpoNovum AB, effective June 17th, 2020.
Updated: May 4
Due to unprecedented situation in Stockholm region caused by the Covid-19 outbreak, the C-REX clinical study has been delayed until further notice.
The scope of the study and the intention to enroll two hundred patients undergoing colon and rectum resections in Stockholm region remains unchanged.
Stefan Tell, MBA takes over as the new CEO of CarpoNovum from January 1, 2020. Former CEO Anders Grönberg moves into the new role as chief medical and operations officer.
